Not intended for U.S. based media
- Merck is broadening its efforts to support
ART clinics to achieve excellence for
patients
- Through leading edge education and training,
the Centre of Excellence aims to
support clinics to achieve consistent
and high level of outcome
DARMSTADT, Germany,
Jan. 20, 2017 /CNW/ - Merck, a
leading science and technology company, today announced the opening
of its first Centre of Excellence (CoE) for fertility. The
objective of the CoE is to provide fertility professionals with a
strong understanding of the concepts, processes and techniques that
are undertaken in high quality clinics in order to help address the
unmet needs in assisted reproductive treatment (ART). The centre
aims to help optimize procedures to improve treatment outcomes for
couples that want to conceive. As a joint venture between Merck and
Genea, a developer of innovative fertility technologies, the CoE
demonstrates the two partners' commitment to support high standards
of education within ART.
"The Centre of Excellence is an international training hub
addressing the global unmet needs within fertility clinics by
promoting standardization of processes for consistently high
treatment outcomes," said Dorothea
Wenzel, Head of the Global Business Franchise Fertility at
the biopharma business of Merck. "Its unique concept is a
reflection of the best practice standard in ART clinics that Merck
and Genea have developed."
The CoE is a state-of-the-art facility for high quality training
of healthcare professionals, such as physicians and embryologists,
to improve clinical practices, protocols and clinic outcome.
Jan Kirsten, Global Head of
Fertility Technologies, further explained: "The participants are
given the opportunity to experience first-hand how leading science
and technologies work in a real clinical environment. Thus, the
concept allows Merck to offer practical hands-on training through a
training lab and the adjacent Genea clinic, alongside theoretical
education." The centre is located in Bangkok, Thailand, and with this central
location in the Asia-Pacific
(APAC) region aims to attract participants from all over the world
with focus on APAC and China. The
CoE was officially opened with a ceremony held on 16 January 2017.
The centre is another collaboration between Merck and Genea,
also supported by the partners of the Global Fertility Alliance
(GFA), which was founded in 2015. The GFA is driving
standardization in ART clinics for improved treatment outcomes.
Therefore, the CoE also represents the innovative technologies from
the GFA partners including Illumina, a leader in developing and
commercializing systems for analysis of genetic variation and
function, ZEISS, an internationally leading technology enterprise
operating in the optics as well as optoelectronics industries and
the associated partner Chart MVE BioMedical, the world's leading
manufacturer of cryogenic freezer systems, as well as the latest
technology in laser systems from Hamilton Thorne, Inc.
All Merck Press Releases are distributed by e-mail at the same
time they become available on the Merck Website. Please go to
http://www.merckgroup.com/subscribe to register online, change your
selection or discontinue this service.
About Merck
Merck is a leading science and technology company in healthcare,
life science and performance materials. Around 50,000 employees
work to further develop technologies that improve and enhance life
- from biopharmaceutical therapies to treat cancer or multiple
sclerosis, cutting-edge systems for scientific research and
production, to liquid crystals for smartphones and LCD televisions.
In 2015, Merck generated sales of € 12.85 billion in 66
countries.
Founded in 1668, Merck is the world's oldest pharmaceutical and
chemical company. The founding family remains the majority owner of
the publicly listed corporate group. Merck, Darmstadt, Germany holds the global rights to the Merck
name and brand. The only exceptions are the United States and Canada, where the company operates as EMD
Serono, MilliporeSigma and EMD Performance Materials.
(Logo:
http://mma.prnewswire.com/media/459341/Merck_Logo.jpg )
(Photo:
http://mma.prnewswire.com/media/459340/Merck_Opening_Ceremony.jpg
)
SOURCE Merck